| Similasan AG - Similasan Reisekrankheit, Tabletten | | 67813 | | 01 | | Similasan Reisekrankheit | | Tabletten | | A04AZ | | Antiemetika, Homöopathika | | 23.11.2021 | | |
| | Composition | | strychnos nux-vomica (HAB) D15 (Ph.Eur.Hom. 1.1.8) 6.25 mg, hyoscyamus niger (HAB) D15 6.25 mg, petroleum rectificatum (HAB) D15 6.25 mg, anamirta cocculus (HAB) D15 (Ph.Eur.Hom. 1.1.8) 6.25 mg, maydis amylum, magnesii stearas, lactosum monohydricum 241.25 mg, pro compresso 250 mg. | | Packungsbestandteile | | Tablets | | | | Active Agent | Dose |
|---|
| Anamirta Cocculus (Hab) D15 (Ph.Eur.Hom. 1.1.8) | 6.25 mg | | Hyoscyamus Niger (Hab) D15 | 6.25 mg | | Petroleum Rectificatum (Hab) D15 | 6.25 mg | | Strychnos Nux-Vomica (Hab) D15 (Ph.Eur.Hom. 1.1.8) | 6.25 mg |
| | | | Inactive agents | Dose |
|---|
| Lactose Monohydrate | 241.25 mg | | Magnesii Stearas | | | Maydis Amylum | | | Pro Compresso | 250 mg |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 60 | PR | PR | D | | Yes |
|
|
